BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fantacuzzi M, Amoroso R, Ammazzalorso A. PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection. Biology (Basel) 2022;11:114. [PMID: 35053112 DOI: 10.3390/biology11010114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Youssef FS, El-Sherbeni SA, Negm WA. A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection. Inflammopharmacology 2022;:1-11. [PMID: 36484974 DOI: 10.1007/s10787-022-01111-x] [Reference Citation Analysis]
2 Sularea VM, Sugrue JA, O'Farrelly C. Innate antiviral immunity and immunometabolism in hepatocytes. Curr Opin Immunol 2022;80:102267. [PMID: 36462263 DOI: 10.1016/j.coi.2022.102267] [Reference Citation Analysis]
3 Zhang H, Alford T, Liu S, Zhou D, Wang J. Influenza virus causes lung immunopathology through down-regulating PPARγ activity in macrophages. Front Immunol 2022;13:958801. [DOI: 10.3389/fimmu.2022.958801] [Reference Citation Analysis]